24/05/2026
A**l cancer management has evolved substantially over the last decades. 🩺✨
Today, definitive chemoradiotherapy remains the standard treatment for most patients with localized a**l squamous cell carcinoma, allowing organ preservation in many cases while maintaining strong oncologic outcomes. 🎯🟣
Modern care relies on multidisciplinary collaboration, evidence-based decision making, early diagnosis, radiation oncology, surgery, and continued advances in prevention and screening. 🔬👩⚕️👨⚕️☢️🏥
Through science, collaboration, and education, outcomes for patients with a**l cancer continue to improve. 💚
Developed by the International A**l Neoplasia Society (IANS) Junior Members community. 🌍
Inspired by contemporary international evidence and the work of leading experts in a**l neoplasia and a**l cancer prevention, including contributions from Dr. Joel M. Palefsky and IANS-affiliated researchers. 📚
📍Sydney, Australia 🇦🇺
**lCancer